Effectiveness, safety and potential predictors of response at week 16 in patients with severe hidradenitis suppurativa treated with secukinumab: A multicenter observational retrospective study

被引：0
|
作者：
Serrano, Pablo Fernandez-Crehuet [3 ,4 ]
Haselgruber-deFrancisco, Sofia [1 ]
Padial-Gomez, Alicia [5 ]
Vasquez-Chinchay, Fiorella [6 ]
Fernandez-Ballesteros, Maria D. [7 ]
Lopez-Riquelme, Irene [7 ]
Jimenez-Gallo, David [8 ]
Segura-Palacios, Juan M. [9 ]
Contreras-Steyls, Marisol [10 ]
Osorio-Gomez, Guiovana F. [11 ]
Hernandez-Rodriguez, Juan Carlos [11 ]
Cuenca-Barrales, Carlos [1 ]
Molina-Leyva, Alejandro [1 ,2 ]
机构：
[1] Hosp Univ Virgen de las Nieves, IBS Granada, Hidradenitis Suppurativa Clin, Granada, Spain
[2] European Hidradenitis Suppurativa Fdn, Dessau Rosslau, Germany
[3] Hosp Reina Sofia Cordoba, Cordoba, Spain
[4] IMIBIC, Dept Dermatol, Cordoba, Spain
[5] Hosp Univ Jerez de la Frontera, Dept Dermatol, Jerez de la Frontera, Spain
[6] Hosp Univ Virgen Valme, Dept Dermatol, Seville, Spain
[7] Hosp Univ Reg Malaga, Dept Dermatol, Malaga, Spain
[8] Hosp Univ Puerta Mar, Dept Dermatol, Cadiz, Spain
[9] Hosp Costa Sol, Dept Dermatol, Marbella, Spain
[10] Hosp Univ Virgen de la Victoria, Dept Dermatol, Malaga, Spain
[11] Hosp Univ Virgen de Rocio, Dept Dermatol, Seville, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study
    Carpentieri, Antonio
    Mascia, Paola
    Fornaro, Marco
    Beylot-Barry, Marie
    Taieb, Alain
    Foti, Caterina
    Loconsole, Francesco
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [22] Potential Predictors of Biological Therapy Intensification in Moderate-To-Severe Hidradenitis Suppurativa: A Multicentre Study
    Ramos, Francisco Javier Melgosa
    Ruiz, Ramon Garcia
    Martorell, Antonio
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2025,
  • [23] Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis - a real life retrospective study
    Galica, Katarzyna
    Lesiak, Aleksandra
    Ciazynska, Magdalena
    Noweta, Marcin
    Bednarski, Igor
    Narbutt, Joanna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2021, 38 (06): : 973 - 978
  • [24] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Andrea Chiricozzi
    Martina Burlando
    Giacomo Caldarola
    Andrea Conti
    Giovanni Damiani
    Clara De Simone
    Valentina Dini
    Piergiorgio Malagoli
    Francesca Peccerillo
    Concetta Potenza
    Emanuele Scala
    Nevena Skroza
    Anna Balato
    American Journal of Clinical Dermatology, 2020, 21 : 441 - 447
  • [25] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Chiricozzi, Andrea
    Burlando, Martina
    Caldarola, Giacomo
    Conti, Andrea
    Damiani, Giovanni
    De Simone, Clara
    Dini, Valentina
    Malagoli, Piergiorgio
    Peccerillo, Francesca
    Potenza, Concetta
    Scala, Emanuele
    Skroza, Nevena
    Balato, Anna
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (03) : 441 - 447
  • [26] Geographic tongue clinical response in moderate-to-severe psoriatic patients undergoing secukinumab: a real-life, multicenter retrospective observational study
    Damiani, G.
    Pacifico, A.
    Malagoli, P.
    Bindi, M.
    Maiorana, C.
    Poli, P.
    Taschieri, S.
    Francetti, L.
    Corbella, S.
    Del Fabbro, M.
    Marino, S.
    Spadari, F.
    Bragazzi, N. L.
    Pigatto, P. D. M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (02): : 331 - 337
  • [27] Effectiveness and safety of intralesional triamcinolone in the management of patients with Hidradenitis Suppurativa: A case series study
    Cuenca-Barrales, C.
    Arias-Santiago, S.
    Molina-Leyva, A.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 27 - 27
  • [28] Secukinumab in moderate to severe hidradenitis suppurativa: Week 16 results of hurley stage II and III from the sunshine and sunrise phase 3 randomized trials
    Kimball, Alexa B.
    Alavi, Afsaneh
    Jemec, Gregor B. E.
    Zouboulis, Christos C.
    Wozniak, Magdalena B.
    Uhlmann, Lorenz
    Llobet-Martinez, Angela
    Ravichandran, Shoba
    Marzano, Angelo V.
    Reguiai, Ziad
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 25 - 26
  • [29] Impact of secukinumab on the need for rescue surgical intervention in patients with moderate to severe hidradenitis suppurativa: Post-hoc analysis of week 16 data from sunshine and sunrise trials
    van der Zee, Hessel H.
    Szepietowski, Jacek C.
    Sayed, Christopher
    Guillem, Philippe
    Hamzavi, Iltefat H.
    Goldberg, Stephanie
    Field, Clarice
    Ortmann, Christine-Elke
    Lobach, Iryna
    Wozniak, Magdalena B.
    Llobet-Martinez, Angela
    Ravichandran, Shoba
    Bachhuber, Teresa
    Bechara, Falk G.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 30 - 31
  • [30] Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in Japan
    Hayashi, Nobukazu
    Hayama, Koremasa
    Takahashi, Kenzo
    Kurokawa, Ichiro
    Okazaki, Masateru
    Kashiwagi, Tomoko
    Iwashita, Eri
    Terui, Tadashi
    JOURNAL OF DERMATOLOGY, 2023, 50 (08): : 1034 - 1044
12345